Current and historical daily PE Ratio for Bharat Immunologicals & Biologicals Corp Ltd (
) from 2000 to May 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bharat Immunologicals & Biologicals stock (BOM:524663) PE ratio as of May 28 2024 is 0.
More Details
Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) PE Ratio (TTM) Chart
Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1228
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Bharat Immunologicals & Biologicals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-28 | At Loss | 2024-03-18 | At Loss |
| 2024-05-27 | At Loss | 2024-03-14 | At Loss |
| 2024-05-24 | At Loss | 2024-03-13 | At Loss |
| 2024-05-23 | At Loss | 2024-03-12 | At Loss |
| 2024-05-22 | At Loss | 2024-03-11 | At Loss |
| 2024-05-21 | At Loss | 2024-03-07 | At Loss |
| 2024-05-17 | At Loss | 2024-03-06 | At Loss |
| 2024-05-16 | At Loss | 2024-03-05 | At Loss |
| 2024-05-15 | At Loss | 2024-03-04 | At Loss |
| 2024-05-14 | At Loss | 2024-03-01 | At Loss |
| 2024-05-13 | At Loss | 2024-02-29 | At Loss |
| 2024-05-10 | At Loss | 2024-02-28 | At Loss |
| 2024-05-09 | At Loss | 2024-02-27 | At Loss |
| 2024-05-08 | At Loss | 2024-02-26 | At Loss |
| 2024-05-07 | At Loss | 2024-02-23 | At Loss |
| 2024-05-06 | At Loss | 2024-02-22 | At Loss |
| 2024-05-03 | At Loss | 2024-02-21 | At Loss |
| 2024-05-02 | At Loss | 2024-02-20 | At Loss |
| 2024-04-30 | At Loss | 2024-02-19 | At Loss |
| 2024-04-29 | At Loss | 2024-02-16 | At Loss |
| 2024-04-26 | At Loss | 2024-02-15 | At Loss |
| 2024-04-25 | At Loss | 2024-02-14 | At Loss |
| 2024-04-24 | At Loss | 2024-02-13 | At Loss |
| 2024-04-23 | At Loss | 2024-02-12 | At Loss |
| 2024-04-22 | At Loss | 2024-02-09 | At Loss |
| 2024-04-19 | At Loss | 2024-02-08 | At Loss |
| 2024-04-18 | At Loss | 2024-02-07 | At Loss |
| 2024-04-16 | At Loss | 2024-02-06 | At Loss |
| 2024-04-15 | At Loss | 2024-02-05 | At Loss |
| 2024-04-12 | At Loss | 2024-02-02 | At Loss |
| 2024-04-10 | At Loss | 2024-02-01 | At Loss |
| 2024-04-09 | At Loss | 2024-01-31 | At Loss |
| 2024-04-08 | At Loss | 2024-01-30 | At Loss |
| 2024-04-05 | At Loss | 2024-01-29 | At Loss |
| 2024-04-04 | At Loss | 2024-01-25 | At Loss |
| 2024-04-03 | At Loss | 2024-01-24 | At Loss |
| 2024-04-02 | At Loss | 2024-01-23 | At Loss |
| 2024-04-01 | At Loss | 2024-01-19 | At Loss |
| 2024-03-28 | At Loss | 2024-01-18 | At Loss |
| 2024-03-27 | At Loss | 2024-01-17 | At Loss |
| 2024-03-26 | At Loss | 2024-01-16 | At Loss |
| 2024-03-22 | At Loss | 2024-01-15 | At Loss |
| 2024-03-21 | At Loss | 2024-01-12 | At Loss |
| 2024-03-20 | At Loss | 2024-01-11 | At Loss |
| 2024-03-19 | At Loss | 2024-01-10 | At Loss |
Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Bharat Immunologicals & Biologicals Corp Ltd
ISIN : INE994B01014
Compare
Compare
Traded in other countries / regions
524663.India IPO Date
2000-03-10Description
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers